Moderna Is Losing Billions. Here's Why That Might Be Exactly the Right Strategy.
On May 6, 2026, Moderna’s board amended its bylaws to require Securities Act of 1933 lawsuits be filed exclusively in US federal district courts, aligning with recent Delaware law changes, while the ...
Lynch syndrome is an inherited condition affecting 1 in 300 people that causes lifetime cancer risk of up to 80%[1]The ...
Global pharmaceutical companies Moderna and MSD announced on the 1st (local time) the results of a joint Phase 2 clinical ...
Moderna secures up to $50 million to develop an Ebola vaccine.
When used alongside Merck’s Keytruda, Moderna’s personalized cancer vaccine halved the risk of death or disease recurrence in ...
Shares of Moderna (NASDAQ:MRNA) are up roughly 6% in Monday morning trading, changing hands near $57.52 after Friday’s close of $54.35. The intraday move extends what has already been a powerful 2026 ...
Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, according to published results.
Oxford and Moderna’s preventive mRNA cancer vaccine enters trials, targeting high-risk Lynch syndrome patients to train ...
A top adviser has resigned from the Food and Drug Administration's (FDA) vaccine advisory committee amid concerns about her ...
Under the plans, CEPI has committed up to $50 million to US-based Moderna for preclinical development and Phase 1 clinical ...
By Jennifer Rigby, Mariam Sunny and Siddhi Mahatole June 1 (Reuters) - Global health organisation CEPI will give roughly $60 million to Moderna and two other groups to accelerate the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results